The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE: Recent evidence indicates that carbon monoxide-releasing molecules (CO-RMs) exhibit potential anti-inflammatory properties. In the present study, we have investigated whether tricarbonyl dichloro ruthenium(II) dimer (CORM-2) can control the inflammatory response induced by cytokines in a human colonic epithelial cell line, Caco-2. EXPERIMENTAL APPROACH: Caco-2 cells were preincubated with CORM-2 for 30 minutes and then stimulated with interleukin (IL)-1beta, tumor necrosis factor-alpha and interferon-gamma for different times. Gene expression was analyzed by real-time PCR. Protein expression was investigated by Western blot and ELISA. Transcription factor activation was determined by the luciferase method. KEY RESULTS: We have shown that CORM-2 significantly decreased the mRNA expression of nitric oxide synthase-2 (NOS-2) and the production of nitrite, in Caco-2 cells stimulated with cytokines. IL-8, IL-6 and metalloproteinase-7 (MMP-7) mRNA and protein were also significantly reduced by CORM-2. Time-course and small interfering RNA studies suggest that inhibition of IL-6 plays a role in the regulation of MMP-7 expression by CORM-2. These effects of CORM-2 can be dependent on the modulation of nuclear factor-kappaB (NF-kappaB), activator protein-1, CCAT/enhancer binding protein and the phosphorylated forms of NF-kappaB inhibitory protein-alpha, c-Jun N-terminal protein kinase 1/2, p38 and extracellular signal-regulated kinase 1/2. CONCLUSIONS AND IMPLICATIONS: CORM-2 can regulate a number of genes relevant in intestinal inflammation and cancer progression. These findings provide new insights into the anti-inflammatory properties and potential applications of this class of compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations suggest that NF-κB is activated because of a lack of HO-1 derived anti-inflammatory molecules (CO, bilirubin) and is consistent with previous findings showing that the CO releasing compound, CORM-2, inhibits the DNA binding activity of NF-κB resulting in reduced TNFα production (Sawle et al., 2005; Megias et al., 2007; Motterlini et al., 2012).”
From Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection: Heme oxygenase 1 expression affects Salmonella infection (2016) · cites this paper as Megias et al., 2007
Citations
Cites
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,496 · cited 1×
“Therefore, NF-kB is considered a therapeutic target for intestinal inflammatory diseases and cancer (Viatour et al., 2005).”
BackgroundHow NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
A Fluorometric Assay for the Measurement of Nitrite in Biological Samples
Misko, T. P., Schilling, R. J., Salvemini, D., Moore, W. M., & Currie, M. G. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1449 · Cited by 1,027 · cited 2×
“levels In supernatants from 18 h cytomix-stimulated cells, NO2 was determined fluorometrically in microtiter plates using NaNO2 as a standard (Misko et al., 1993).”
MethodCarbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities
Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E., & Green, C. J. (2002) · Circulation Research · doi:10.1161/hh0202.104530 · Cited by 998 · cited 2×
“The concentrations used are in the range of those previously reported in other cell lines (Motterlini et al., 2002) and Caco-2 cells (Busserolles et al., 2006).”
BackgroundWinzen, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.4969 · Cited by 777 · cited 2×
“On the other hand, p38 or ERK1/2 can play a role in the stabilization of IL-6 or IL-8 mRNA (Winzen et al., 1999; Choi et al., 2004).”
BackgroundJaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 734
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Gross, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715 · cited 2×
“Activation of NF-kB by cytokines correlates with the degree of mucosal inflammation in inflammatory bowel disease (Rogler et al., 1998) and plays a key role in NOS-2 and IL-8 induction (Nunokawa et al., 1996; Roebuck, 1999).”
BackgroundVanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M. L., Fiers, W., & Haegeman, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3285 · Cited by 679 · cited 1×
“Upon activation by stress and inflammatory cytokines, p38 translocates to the nucleus and regulates various transcription factors (Vanden Berghe et al., 1998).”
BackgroundCardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673 · cited 2×
“, 2004) and cardioprotective (Clark et al., 2003) effects of this group of compounds.”
BackgroundIntestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. M., & Matrisian, L. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1402 · Cited by 609 · cited 2×
“Therefore, absence of MMP-7 may inhibit intestinal neoplasia in mice (Wilson et al., 1997) and would reduce the risk of progression from ulcerative colitis-related low-grade dysplasia to cancer (Newell et al.”
BackgroundSoares, M. P., Seldon, M. P., Gregoire, I. P., Vassilevskaia, T., Berberat, P. O., Yu, J., Tsui, T.-Y., & Bach, F. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3553 · Cited by 465
Gross, S. S., & Levi, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35667-9 · Cited by 443 · cited 1×
“The medium was then removed and the cells solubilized in dimethyl sulfoxide (DMSO) (100 ml) to quantitate formazan at 550 nm (Gross and Levi, 1992).”
MethodRegulation of Interleukin-8 Gene Expression
Roebuck, K. A. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313866 · Cited by 415 · cited 4×
“…cytokines activate nuclear factor-kB (NF-kB), which regulates the transcription of nitric oxide synthase-2 (NOS-2), interleukin(IL)-8, IL-6, matrix metalloproteinases (MMPs) and other molecules involved in chronic intestinal inflammation and cancer (Roebuck, 1999; Jobin and Sartor, 2000).”
BackgroundInfluentialInduction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells
Mizukami, Y., Jo, W.-S., Duerr, E.-M., Gala, M., Li, J., Zhang, X., Zimmer, M. A., Iliopoulos, O., Zukerberg, L. R., Kohgo, Y., et al. (2005) · Nature Medicine · doi:10.1038/nm1294 · Cited by 406 · cited 2×
“Increased production of IL-8 in the presence of bacteria or intestinal inflammation has been related to malignant transformation, cell growth, metastasis and angiogenesis in colon cancer cells (Mizukami et al., 2005).”
BackgroundCarbon monoxide in biology and medicine
Ryter, S. W., & Otterbein, L. E. (2004) · BioEssays · doi:10.1002/bies.20005 · Cited by 392 · cited 1×
“The protective actions of HO-1 in the gut may be mediated by the production of biliverdin, bilirubin (Berberat et al., 2005; Busserolles et al., 2006) or CO (reviewed in Ryter and Otterbein, 2004).”
BackgroundSawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706241 · Cited by 391 · cited 4×
“As CO and CORM-2 may induce HO-1 (Sawle et al., 2005), which could inhibit NO production (Turcanu et al., 1998), we assessed the effect of CORM-2 on HO-1 protein expression.”
BackgroundInfluentialThe IκB/NF-κB system: a key determinant of mucosal inflammation and protection
Jobin, C., & Sartor, R. B. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.3.c451 · Cited by 386 · cited 3×
“…cytokines activate nuclear factor-kB (NF-kB), which regulates the transcription of nitric oxide synthase-2 (NOS-2), interleukin(IL)-8, IL-6, matrix metalloproteinases (MMPs) and other molecules involved in chronic intestinal inflammation and cancer (Roebuck, 1999; Jobin and Sartor, 2000).”
BackgroundSuppression of Inflammatory Cytokine Production by Carbon Monoxide Involves the JNK Pathway and AP-1
Morse, D., Pischke, S. E., Zhou, Z., Davis, R. J., Flavell, R. A., Loop, T., Otterbein, S. L., Otterbein, L. E., & Choi, A. M. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302942200 · Cited by 373 · cited 2×
“, 2005), and a murine model of shock via AP-1 inhibition (Morse et al., 2003).”
BackgroundMatrix metalloproteinase levels are elevated in inflammatory bowel disease
Baugh, M. D., Perry, M. J., Hollander, A. P., Davies, D. R., Cross, S. S., Lobo, A. J., Taylor, C. J., & Evans, G. S. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70339-2 · Cited by 328 · cited 2×
“MMPs can be effector molecules for mucosal injury and play an important role in inflammatory bowel disease (Baugh et al., 1999) and early stages of colorectal carcinogenesis (Nosho et al., 2005).”
BackgroundVasoactive properties of CORM‐3, a novel water‐soluble carbon monoxide‐releasing molecule
Foresti, R., Hammad, J., Clark, J. E., Johnson, T. R., Mann, B. E., Friebe, A., Green, C. J., & Motterlini, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705825 · Cited by 303 · cited 2×
“Recent data have demonstrated the vasoactive (Foresti et al., 2004) and cardioprotective (Clark et al., 2003) effects of this group of compounds.”
BackgroundEvidence for continuous stimulation of interleukin-6 production in Crohn's disease
Gross, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293 · cited 2×
“tory conditions such as inflammatory bowel disease (Gross et al., 1992).”
BackgroundIncreased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig, R., Andus, T., Aschenbrenner, E., Falk, W., Schölmerich, J., & Gross, V (1996) · Gut · doi:10.1136/gut.38.2.216 · Cited by 291 · cited 2×
“The expression of IL-8 correlates with mucosal inflammation in both ulcerative colitis and Crohn’s disease (Daig et al., 1996).”
BackgroundAmbs, S., Merriam, W. G., Ogunfusika, M. O., Bennett, W. P., Ishibe, N., Hussain, S. P., Tzeng, E. E., Geller, D. A., Billiar, T. R., & Harris, C. C. (1998) · Nature Medicine · doi:10.1038/3957 · Cited by 287 · cited 2×
“High levels of NO can damage DNA or inhibit repair (Jaiswal et al., 2000), enhance angiogenesis and favor tumor progression (Ambs et al., 1998; Hellmuth et al., 2004).”
BackgroundMazzucchelli, L., Hauser, C. J., Z’graggen, K., Wagner, H., Hess, M. W., Laissue, J. A., & Mueller, C. (1994) · PubMed Central · Cited by 286
Nuclear factor-κB is upregulated in colorectal cancer
Lind, D. S., Hochwald, S. N., Malaty, J., Rekkas, S., Hebig, P., Mishra, G., Moldawer, L. L., Copeland, E. M., & MacKay, S. (2001) · Surgery · doi:10.1067/msy.2001.116672 · Cited by 269 · cited 1×
“Activa- tion of this transcription factor has been observed in Crohn’s disease and ulcerative colitis (reviewed in Jobin and Sartor, 2000), as well as in intestinal tumor development (Greten et al., 2004), human colon cancer cell lines and human colorectal cancer (Lind et al., 2001).”
BackgroundJobin, C., Panja, A. B., Hellerbrand, C., Iimuro, Y., DiDonato, J. A., Brenner, D. A., & Sartor, R. B. (1998) · PubMed · Cited by 224
Li, A., Varney, M. L., & Singh, R. K. (2001) · PubMed · Cited by 214
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Witty, J. P., McDonnell, S., Newell, K. J., Cannon, P., Navre, M., Tressler, R. J., & Matrisian, L. M. (1994) · PubMed · Cited by 185
Sarady, J. K., Zuckerbraun, B. S., Bilban, M., Wagner, O., Usheva, A., Liu, F., Ifedigbo, E., Zamora, R., Choi, A. M. K., & Otterbein, L. E. (2004) · The FASEB Journal · doi:10.1096/fj.03-0643fje · Cited by 177 · cited 2×
“In a model of rat endotoxemia, CO has been shown to prevent the upregulation of NOS-2 in the lung while increasing NOS-2 expression in the liver (Sarady et al., 2004).”
BackgroundCrawford, H. C., Fingleton, B., Gustavson, M. D., Kurpios, N., Wagenaar, R. A., Hassell, J. A., & Matrisian, L. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1370-1383.2001 · Cited by 175 · cited 10×
“Previous studies have reported that CO inhibited the production of IL-6 in murine macrophages and lung cells (Kim et al., 2005), and a murine model of shock via AP-1 inhibition (Morse et al., 2003).”
BackgroundInfluentialJobin, C., Panja, A., Hellerbrand, C., Iimuro, Y., Didonato, J., Brenner, D. A., & Sartor, R. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.410 · Cited by 171 · cited 2×
“CORM-2 inhibits the activation of NF-kB, AP-1 and C/EBP As NF-kB activation is essential for cytokine-mediated inflammation and transcription of NOS-2 and IL-8 in human intestinal epithelial cells (Jobin et al., 1998), and production of IL-6 in Caco-2 cells cells after IL-1b stimulation has been related to the activat…”
BackgroundProtective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats
Wang, W. P., Guo, X., Koo, M. W. L., Wong, B. C. Y., Lam, S. K., Ye, Y. N., & Cho, C. H. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.2.g586 · Cited by 144 · cited 2×
“the anti-inflammatory effects observed in animals (Wang et al., 2001; Paul et al., 2005), HO-1 has been proposed as”
BackgroundKim, H. P., Wang, X., Zhang, J., Suh, G. Y., Benjamin, I. J., Ryter, S. W., & Choi, A. M. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2622 · Cited by 139 · cited 2×
“production of IL-6 in murine macrophages and lung cells (Kim et al., 2005), and a murine model of shock via AP-1 inhibition (Morse et al.”
BackgroundAnalysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis
Paul, G., Bataille, F., Obermeier, F., Bock, J., Klebl, F., Strauch, U., Lochbaum, D., Rümmele, P., Farkas, S., Schölmerich, J., et al. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02775.x · Cited by 117 · cited 4×
“the anti-inflammatory effects observed in animals (Wang et al., 2001; Paul et al., 2005), HO-1 has been proposed as”
BackgroundInfluentialHeme Oxygenase-1-Generated Biliverdin Ameliorates Experimental Murine Colitis
Berberat, P. O., A-Rahim, Y. I., Yamashita, K., Warny, M. M., Csizmadia, E., Robson, S. C., & Bach, F. H. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000164017.06538.8a · Cited by 114 · cited 2×
“The protective actions of HO-1 in the gut may be mediated by the production of biliverdin, bilirubin (Berberat et al., 2005; Busserolles et al., 2006) or CO (reviewed”
BackgroundParikh, A. A., Salzman, A. L., Kane, C. D., Fischer, J. E., & Hasselgren, P.-O. J. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5061 · Cited by 102 · cited 8×
“cells by proinflammatory cytokines has been related to activation of NF-kB (Parikh et al., 1997), AP-1 (Hungness et al.”
BackgroundInfluentialKaizu, T., Nakao, A., Tsung, A., Toyokawa, H., Sahai, R., Geller, D. A., & Murase, N. (2005) · Surgery · doi:10.1016/j.surg.2005.06.015 · Cited by 100 · cited 1×
“In contrast, CO shows no effect on this transcription factor in activated endothelial cells (Soares et al., 2004) and the protection against hepatic ischemia/reperfusion injury by CO administration is not associated with inhibition of NF-kB signaling (Kaizu et al., 2005).”
BackgroundHeme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway
Busserolles, J., Megías, J., Terencio, M. C., & Alcaraz, M. J. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.03.013 · Cited by 99 · cited 3×
“The concentrations used are in the range of those previously reported in other cell lines (Motterlini et al., 2002) and Caco-2 cells (Busserolles et al., 2006).”
BackgroundSelf-citationSalmela, M. T., Pender, S. L. F., Karjalainen-Lindsberg, M.-L., Puolakkainen, P., MacDonald, T. T., & Saarialho-Kere, U. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410003470 · Cited by 96 · cited 2×
“This enzyme could participate in wound healing (Salmela et al., 2004), leading to migration of epithelial cells after tissue damage.”
BackgroundNunokawa, Y., Oikawa, S., & Tanaka, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0897 · Cited by 93 · cited 2×
“Activation of NF-kB by cytokines correlates with the degree of mucosal inflammation in inflammatory bowel disease (Rogler et al., 1998) and plays a key role in NOS-2 and IL-8 induction (Nunokawa et al., 1996; Roebuck, 1999).”
BackgroundGarat, C. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00182-0 · Cited by 92 · cited 1×
“It is known that this MAPK may facilitate NF-kB-dependent gene transcription in Caco-2 cells (Garat and Arend, 2003) and may also regulate IL-8 expression independently of NF-kB.”
BackgroundHeme oxygenase‐1: a new therapeutic target for inflammatory bowel disease
Naito, Y., Takagi, T., & Yoshikawa, T. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01992.x · Cited by 91 · cited 2×
“a new therapeutic target for inflammatory bowel disease (Naito et al., 2004).”
BackgroundBanihani, M., Greenstein, D., Mann, B. E., Green, C. J., & Motterlini, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104729 · Cited by 86 · cited 2×
“, 2005) or microglia (Bani-Hani et al., 2006) cell lines.”
BackgroundMatsuno, K., Adachi, Y., Yamamoto, H., Goto, A., Arimura, Y., Endo, T., Itoh, F., & Imai, K. (2003) · Journal of Gastroenterology · doi:10.1007/s005350300062 · Cited by 84 · cited 2×
“, 2002), as well as a marker of activity related to dysplasia and cancer in patients with ulcerative colitis (Matsuno et al., 2003).”
BackgroundRivat, C., Le Floch, N., Sabbah, M., Teyrol, I., Redeuilh, G., Bruyneel, E., Mareel, M., Matrisian, L. M., Crawford, H. C., Gespach, C., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0132fje · Cited by 81 · cited 2×
“…participation in inflammatory responses, MMP-7 is a transcriptional target of the src oncogenic pathway in colonic cancer cells, which may contribute to tumorigenicity, cellular invasion and the metastatic potential of cancer cells (Witty et al., 1994; Yamamoto et al., 1995; Rivat et al., 2003).”
BackgroundMatrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?
Wielockx, B., Libert, C., & Wilson, C. L. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.12.001 · Cited by 79 · cited 4×
“, 2005) and several inflammatory disorders (Wielockx et al., 2004).”
BackgroundInfluentialMühlbauer, M., Allard, B., Bosserhoff, A. K., Kiessling, S., Herfarth, H., Rogler, G., Schölmerich, J., Jobin, C., & Hellerbrand, C. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00338.2003 · Cited by 78 · cited 2×
“The primer sequences have been reported elsewhere: IL-8 (Muhlbauer et al., 2004), IL-6 (www.”
BackgroundLópez‐Collazo, E., Hortelano, S., Rojas, A., & Boscá, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2889 · Cited by 73 · cited 1×
“Nuclear extracts were prepared as described (López-Collazo et al., 1998).”
MethodChoi, E.-Y., Kim, E.-C., Oh, H.-M., Kim, S., Lee, H.-J., Cho, E.-Y., Yoon, K.-H., Kim, E.-A., Han, W.-C., Choi, S.-C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7069 · Cited by 69 · cited 1×
“On the other hand, p38 or ERK1/2 can play a role in the stabilization of IL-6 or IL-8 mRNA (Winzen et al., 1999; Choi et al., 2004).”
BackgroundParhar, K. K. S., Ray, A., Steinbrecher, U. P., Nelson, C. C., & Salh, B. S. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01603.x · Cited by 69 · cited 1×
“Although its precise role in intestinal inflammation is not known, attenuation of p38 may result in anti-inflammatory effects in conditions such as inflammatory bowel disease (Parhar et al., 2003).”
BackgroundSuppression of matrilysin inhibits colon cancer cell invasion in vitro
Yamamoto, H., Itoh, F., Hinod, Y., & Imai, K. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610213 · Cited by 68 · cited 2×
“…participation in inflammatory responses, MMP-7 is a transcriptional target of the src oncogenic pathway in colonic cancer cells, which may contribute to tumorigenicity, cellular invasion and the metastatic potential of cancer cells (Witty et al., 1994; Yamamoto et al., 1995; Rivat et al., 2003).”
BackgroundLópez‐Collazo, E., Hortelano, S., Armando Rojas, R., et al. (1998) · PubMed · Cited by 65
Transcription factors C/EBP‐β and ‐δ regulate IL‐6 production in IL‐1β‐stimulated human enterocytes
Hungness, E. S., Luo, G., Pritts, T. A., Sun, X., Robb, B. W., Hershko, D., & Hasselgren, P. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10116 · Cited by 57 · cited 11×
“Cells were preincubated with CORM-2 for 30 min and then stimulated with a mixture of proinflammatory cytokines (cytomix) – interferon-g (1000 U ml 1), IL-1b (10 ng ml 1) and TNFa (10 ng ml 1) – for different times.”
BackgroundInfluentialTurcanu, V., Dhouib, M., & Poindron, P. (1998) · Research in Immunology · doi:10.1016/s0923-2494(99)80050-9 · Cited by 57 · cited 1×
“As CO and CORM-2 may induce HO-1 (Sawle et al., 2005), which could inhibit NO production (Turcanu et al., 1998), we assessed the effect of CORM-2 on HO-1 protein expression.”
BackgroundDijkstra, G. D. H., Blokzijl, H., Bok, L. I. H., Buist‐Homan, M., van Goor, H., Faber, K. N., Jansen, P. L. M., & Moshage, H. J. (2004) · The Journal of Pathology · doi:10.1002/path.1656 · Cited by 56 · cited 4×
“The HO-1 isoform is induced by oxidative stress in colonic epithelial cells (Dijkstra et al., 2004) and can be detected in the intestinal epithelium of severely inflamed mucosa of inflam- matory bowel disease patients (Paul et al., 2005).”
BackgroundResultInfluentialNosho, K., Yoshida, M., Yamamoto, H., Taniguchi, H., Adachi, Y., Mikami, M., Hinoda, Y., & Imai, K. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi029 · Cited by 51 · cited 2×
“MMPs can be effector molecules for mucosal injury and play an important role in inflammatory bowel disease (Baugh et al., 1999) and early stages of colorectal carcinogenesis (Nosho et al., 2005).”
BackgroundMinamoto, K., Harada, H., Lama, V. N., Fedarau, M. A., & Pinsky, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050377 · Cited by 48 · cited 2×
“Similarly, CO inhalation inhibits NF-kBbinding ability and NOS-2 expression after tracheal transplantation in mice (Minamoto et al., 2005).”
BackgroundBister, V., Salmela, M. T., Heikkil�, P., Anttila, A., Rintala, R. J., Isaka, K., Andersson, S., & Saarialho‐Kere, U. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200501000-00011 · Cited by 44 · cited 2×
“…of Pharmacology (2007) 150, 977–986 & 2007 Nature Publishing Group All rights reserved 0007–1188/07 $30.00 www.brjpharmacol.org therapeutic option for intestinal inflammation associated with necrotizing enterocolitis (Bister et al., 2005) and several inflammatory disorders (Wielockx et al., 2004).”
BackgroundInfluentialMatrilysin (matrix metalloproteinase‐7) expression in ulcerative colitis–related tumorigenesis†
Newell, K. J., Matrisian, L. M., & Driman, D. K. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10049 · Cited by 43 · cited 4×
“Previous work has noted that MMP-7 expression is induced in inflamed human colon epithelia, but the cellular mechanisms responsible for this response are unclear (Newell et al., 2002).”
BackgroundInfluentialLynch, C. C., Crawford, H. C., Matrisian, L. M., & McDonnell, S. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.6.1565 · Cited by 42 · cited 1×
“In intestinal tumors, MMP-7 expression is British Journal of Pharmacology (2007) 150 977–986 regulated by the PEA3 Ets transcription factor (Lynch et al., 2004), which could enhance transcriptional responses to both b-catenin and AP-1 (Crawford et al., 2001).”
BackgroundHungness, E. S., Pritts, T. A., Luo, G.-J., Sun, X., Penner, G. C., & Hasselgren, P.-O. (2000) · Shock · doi:10.1097/00024382-200014030-00025 · Cited by 41 · cited 10×
“Previous studies have reported that CO inhibited the production of IL-6 in murine macrophages and lung cells (Kim et al., 2005), and a murine model of shock via AP-1 inhibition (Morse et al., 2003).”
BackgroundInfluentialDesmard, M., Amara, N., Lanone, S., Motterlini, R., & Boczkowski, J. (2005) · PubMed · Cited by 37
Foresti, R., Shurey, C. B., Ansari, T., Sibbons, P. D., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R. (2005) · PubMed · Cited by 35
Yanagisawa, N., Geironson, L., Al‐Soud, W. A., & Ljungh, Å. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.11.009 · Cited by 30 · cited 2×
“org), MMP-7 (Yanagisawa et al., 2005), NOS-2 and b-actin (Thilakawardhana et al.”
Continuous cytokine exposure of colonic epithelial cells induces DNA damage
Seidelin, J. B., & Nielsen, O. H. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200503000-00017 · Cited by 27 · cited 2×
“In chronic intestinal inflammation, continuous proinflammatory cytokine stimulation leads to NOS-2 upregulation and NO production, a possible risk factor for colorectal cancer (Seidelin and Nielsen, 2005).”
BackgroundMaliner, M. S., Klein, R. D., Udayakumar, T. S., Nagle, R. B., & Bowden, G. T. (2001) · Neoplasia · doi:10.1038/sj.neo.7900178 · Cited by 25 · cited 5×
“Cells were preincubated with CORM-2 for 30 min and then stimulated with a mixture of proinflammatory cytokines (cytomix) – interferon-g (1000 U ml 1), IL-1b (10 ng ml 1) and TNFa (10 ng ml 1) – for different times.”
BackgroundInfluentialHungness, E. S., Pritts, T. A., Luo, G., Hershko, D., Robb, B. W., & Hasselgren, P. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00129-7 · Cited by 24 · cited 11×
“Cells were preincubated with CORM-2 for 30 min and then stimulated with a mixture of proinflammatory cytokines (cytomix) – interferon-g (1000 U ml 1), IL-1b (10 ng ml 1) and TNFa (10 ng ml 1) – for different times.”
BackgroundInfluentialThilakawardhana, S. B., Everett, D. M., Murdock, P. R., Dingwall, C., & Owen, J. S. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.004 · Cited by 22 · cited 2×
“, 2005), NOS-2 and b-actin (Thilakawardhana et al., 2005).”
Hellmuth, M., Paulukat, J., Ninic, R., Pfeilschifter, J. M., & Mühl, H. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00275-3 · Cited by 20 · cited 2×
“High levels of NO can damage DNA or inhibit repair (Jaiswal et al., 2000), enhance angiogenesis and favor tumor progression (Ambs et al., 1998; Hellmuth et al., 2004).”
Background
Cited by
Niesel, J., Pinto, A., Peindy N'Dongo, H. W., Merz, K., Ott, I., Gust, R., & Schatzschneider, U. (2008) · Chemical Communications · doi:10.1039/b719075a · Cited by 267
Heme oxygenase-1 in tumor biology and therapy
Was, H., Dulak, J., & Jozkowicz, A. (2010) · Current Drug Targets · doi:10.2174/1389450111009011551 · Cited by 259
Use of carbon monoxide as a therapeutic agent: promises and challenges
Foresti, R., Bani-Hani, M. G., & Motterlini, R. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1011-1 · Cited by 251
NIR‐Responsive On‐Demand Release of CO from Metal Carbonyl‐Caged Graphene Oxide Nanomedicine
He, Q., Kiesewetter, D. O., Qu, Y., Fu, X., Fan, J., Huang, P., Liu, Y., Zhu, G., Liu, Y., Qian, Z., et al. (2015) · Advanced Materials · doi:10.1002/adma.201502762 · Cited by 211
Motterlini, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351142 · Cited by 173
Metadata
- Authors
- Megías, J., Busserolles, J., & Alcaraz, M. J.
- Affiliations
- Universitat de València (ES)
- Corresponding author
- Alcaraz, M J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-04
- Volume
- 150
- Issue
- 8
- Pages
- 977-986
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2013913
- OpenAlex
- W1484225253
- Cited by
- 117
- References
- 70
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 11 · 2014: 12 · 2013: 6 · 2012: 7
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Generalitat Valenciana
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- CORM-2, carbon monoxide-releasing molecules, anti-inflammatory activity, intestinal inflammation, Caco-2 cells, cytokine-induced inflammation, IL-1β, TNF-α, interferon-gamma, nitric oxide synthase 2, nitrite production, interleukin-6, MMP-7, NF-κB, AP-1, CREB, MAPK signaling, c-Jun N-terminal kinase, p38 MAPK, ERK1/2, colonic epithelium
- MeSH terms
- NF-KappaB Inhibitor alpha, Anti-Inflammatory Agents, Carbon Monoxide, Dose-Response Relationship, Drug, Epithelial Cells, Humans, Inflammation, Interferon-gamma, Intestinal Mucosa, Organometallic Compounds, Phosphorylation, RNA, Messenger, Time Factors, Tumor Necrosis Factor-alpha, Interleukin-6, Gene Expression, Cytokines, Interleukin-8, NF-kappa B, Transcription Factor AP-1, Caco-2 Cells, I-kappa B Proteins, Matrix Metalloproteinase 7, MAP Kinase Signaling System, CCAAT-Enhancer-Binding Proteins, Nitric Oxide Synthase Type II, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.